methylphenidate hydrochloride tablet film coated extended release
1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies ( 14 )] . Methylphenidate hydrochloride extended-release tablets are a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. ( 1 )
actavis pharma, inc.
OVAL GRAY LOGO 734
LOGO 734 OVAL GRAY
Related Pills
24 HR Methylphenidate Hydrochloride 54 MG Extended Release Oral Tablet
actavis pharma, inc.
methylphenidate hydrochloride tablet film coated extended release
actavis pharma, inc.
methylphenidate hydrochloride tablet film coated extended release
actavis pharma, inc.
methylphenidate hydrochloride tablet film coated extended release
actavis pharma, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, USP are available as follows: 18 mg – Each yellow, film-coated, capsule shaped tablet imprinted with the Andrx logo and 725 on one side and plain on the other side contains 18 mg
METHYLPHENIDATE HYDROCHLORIDE, USP. Tablets are supplied in bottles of 100 (NDC 62037-725-01). 27 mg – Each gray, film-coated, capsule shaped tablet imprinted with the Andrx logo and 734 on one side and plain on the other side contains 27 mg
METHYLPHENIDATE HYDROCHLORIDE, USP. Tablets are supplied in bottles of 100 (NDC 62037-734-01). 36 mg – Each white, film-coated, capsule shaped tablet imprinted with the Andrx logo and 726 on one side and plain on the other side contains 36 mg
METHYLPHENIDATE HYDROCHLORIDE, USP. Tablets are supplied in bottles of 100 (NDC 62037-726-01). 54 mg – Each red brown, film-coated, capsule shaped tablet imprinted with the Andrx logo and 727 on one side and plain on the other side contains 54 mg
METHYLPHENIDATE HYDROCHLORIDE, USP. Tablets are supplied in bottles of 100 (NDC 62037-727-01). Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from humidity. Dispense in tight, light-resistant container as defined in USP, with a child-resistant closure (as required).
More pills like OVAL LOGO 734